Evidence-Based Medicine Guidelines
Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Combined Chemo-endocrine Adjuvant Therapy for Patients With Operable Breast Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451132/all/Combined_chemo_endocrine_adjuvant_therapy_for_patients_with_operable_breast_cancer.
Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451132/all/Combined_chemo_endocrine_adjuvant_therapy_for_patients_with_operable_breast_cancer. Accessed September 19, 2024.
Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451132/all/Combined_chemo_endocrine_adjuvant_therapy_for_patients_with_operable_breast_cancer
Combined Chemo-endocrine Adjuvant Therapy for Patients With Operable Breast Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 September 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451132/all/Combined_chemo_endocrine_adjuvant_therapy_for_patients_with_operable_breast_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer
ID - 451132
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451132/all/Combined_chemo_endocrine_adjuvant_therapy_for_patients_with_operable_breast_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
